NCT01634256

A Human Trial to Evaluate the Efficacy and Safety of Fermented Turmeric in Subjects Showing Mild Hepatic Injury

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Chonbuk National University Hospital · Academic / Other
• Sex: All
• Age: 19 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The investigators performed a double-blind parallel study in a group of showing mild hepatic injury subjects who were given Fermented turmeric over a period of 12 weeks. The investigators measured liver function parameters , including ALT(Alanine Transaminase), AST(Aspartate Transaminase), ALP(Alkaline Phosphatase), γ-GT(Gamma-Glutamyl Transferase), and serum bilirubin, and monitored their blood pressure.

Conditions

• Mild Hepatic Injury

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Placebo	Placebo(3.0g/day)
DIETARY_SUPPLEMENT	Fermented turmeric	Fermented turmeric(3.0g/day)

Timeline

• Start date: 2011-02-01
• Primary completion: 2011-10-01
• Completion: 2012-01-01
• First posted: 2012-07-06
• Last updated: 2012-10-04
• Results posted: 2012-10-04

Locations

1 site across 1 country: South Korea